AI Article Synopsis

  • - The high incidence of HER2-positive breast cancer poses a serious concern due to its elevated mortality rates, making early detection crucial for effective treatment and improved patient outcomes.
  • - This study explores the development of DOTA-A9 peptide and its pegylated version, which were radiolabeled using a specific isotope to enhance tumor targeting and reduce non-target tissue uptake.
  • - The new radiopeptides showed strong binding to breast cancer cells and effective clearance from normal organs, with enhanced tumor visibility in imaging studies, highlighting their potential as promising tools for targeting HER2-positive tumors in future clinical applications.

Article Abstract

Highest global cancer incidence of female breast cancer is a matter of great concern. HER2-positive breast cancers have high mortality rate hence detection at an early stage is vital for successful treatment, improved cancer care and survival rate. Radiolabeled peptides have emerged as new alternatives to radiolabeled antibodies to overcome the limitations of slow clearance and uptake in non-target tissues. Herein, DOTA-A9 peptide and its pegylated variant were constructed on solid phase and radiolabeled with [Lu]LuCl. [Lu]DOTA-A9 and [Lu]DOTA-PEG-A9 displayed high binding affinity (K = 48.4 ± 1.4 and 55.7 ± 12.3 nM respectively) in human breast carcinoma SKBR3 cells. Two radiopeptides exhibited renal excretion and rapid clearance from normal organs. Uptake in SKBR3 tumor and tumor-to-background ratios were significantly higher (p < 0.05) for [Lu]DOTA-PEG-A9 at the three time points investigated. Xenografts could be clearly visualized by [Lu]DOTA-PEG-A9 in SPECT images at 3, 24 and 48 h p.i. indicating the potential for further exploration as HER2-targeting probe. The encouraging in vivo profile of PEG construct, [Lu]DOTA-PEG-A9 incentivizes future studies for clinical applications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489682PMC
http://dx.doi.org/10.1038/s41598-022-19201-9DOI Listing

Publication Analysis

Top Keywords

synthesis comparative
4
comparative evaluation
4
evaluation lu-labeled
4
lu-labeled peg
4
peg non-peg
4
non-peg variant
4
variant peptides
4
peptides her2-targeting
4
her2-targeting probes
4
probes highest
4

Similar Publications

Introduction: The risk of HCC is twice as high in diabetic patients compared to non-diabetic ones, suggesting that diabetes advances carcinogenesis in the liver through a variety of mechanisms. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been shown to improve liver outcomes, emerging as promising agents to treat hepatocellular carcinoma (HCC) in patients with type 2 diabetes mellitus (T2DM).

Methods: We searched PubMed and Scopus databases for articles presenting an association between SGLT2is and HCC to explore the putative mechanisms of action underlying the anti-proliferative activity of SGLT2is.

View Article and Find Full Text PDF

Dual single-atom catalysts have attracted considerable research interest due to their higher metal atom loading and more flexible active sites compared to single-atom catalysts (SACs). We pioneered the one-step synthesis of sheets copper-cobalt graphitic carbon nitride dual single-atom (S-Cu/Co-g-C3N4) using folding fan-shaped aluminum foil as a template, and used them as catalysts in the epoxidation of styrene respectively. Through XAFS(X-ray Absorption Fine Structure) and other characterizations, it is found that Cu and Co single atoms are stabilized separately on g-C3N4 via coordination with nitrogen (N), hindered the ordered growth of sheets, and formed more pore structures, which not only increased more catalytically active sites, but also effectively prevented the flakes re-aggregate during the catalytic process.

View Article and Find Full Text PDF

The accurate discrimination among various volatile organic compounds, especially ethanol and acetone possess a serious concern for metal oxide based chemiresistive sensors. The work presents a systematic approach to address the issue by utilizing superior sensing potentiality of Zn0.5Ni0.

View Article and Find Full Text PDF

An optical BOD biosensor based on intracellular ATP measurements in genetically modified Saccharomyces cerevisiae.

Anal Sci

December 2024

School of Bioscience and Biotechnology, Tokyo University of Technology, 1404-1 Katakura, Hachioji, Tokyo, 192-0982, Japan.

A biosensor for biochemical oxygen demand (BOD) was developed based on intracellular 5'-adenosine triphosphate (ATP) measurements in Saccharomyces cerevisiae. Intracellular ATP was measured using an engineered protein named ATeam, comprising a bacterial FF-ATP synthase ε subunit sandwiched between cyan fluorescent protein and mVenus, a modified yellow fluorescent protein. Because the binding of ATP to ATeam induces changes in the fluorescence spectra owing to Fӧrster resonance energy transfer, S.

View Article and Find Full Text PDF

Objectives: Distal femur fractures (DFF) are frequently treated surgically with single traditional constructs (STC), such as with a lateral plate or intramedullary nail, although nail-plate combination constructs (NPCC) are gaining attention. The purpose of this study is to compare outcomes between NPCC and STC for surgical fixation of DFF to guide surgeon decision-making.

Methods: Data Sources: This study is a systematic review and meta-analysis using PubMed, CINAHL, MEDLINE, Web of Science, Science Direct, and SPORTDiscus from database inception until January 10th, 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!